Trials / Completed
CompletedNCT03370848
Effects of Psyllium on Niacin Tolerability
A Prospective Randomized, Open-Label, Crossover Study on the Effects of Psyllium on Niacin Tolerability
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- VA Greater Los Angeles Healthcare System · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether psyllium is effective in reducing flushing due to niacin and also to measure the effect of niacin on cholesterol levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Psyllium | Aspirin 325 mg tablet and two 1.7gm psyllium wafers (3.4gm total) 30 minutes prior to niacin ER |
| DRUG | Aspirin | Aspirin 325 mg tablet 30 minutes prior to niacin ER |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2017-12-12
- Last updated
- 2017-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03370848. Inclusion in this directory is not an endorsement.